High preoperative serum CA 19-9 levels can predict poor oncologic outcomes in colorectal cancer patients on propensity score analysis.

Jung Kyong ShinHee Cheol KimWoo Yong LeeSeong Hyeon YunYong Beom ChoJung Wook HuhYoon Ah ParkHo-Kyung Chun

Published in: Annals of surgical treatment and research (2018)

Patients with an elevated preoperative CA 19-9 level in colorectal cancer have a significantly poorer prognosis than those with normal levels of CA 19-9. We therefore suggest preoperative CA 19-9 level can be used as an additional prognostic indicator of poor outcomes in colorectal cancer.

Keyphrases

patients undergoing
end stage renal disease
protein kinase
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
metabolic syndrome
adipose tissue
robot assisted
minimally invasive
insulin resistance
glycemic control